Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
0.7803
+0.0122 (1.59%)
At close: Jul 17, 2026, 4:00 PM EDT
0.7900
+0.0097 (1.24%)
After-hours: Jul 17, 2026, 7:57 PM EDT
Celularity Market Cap
Celularity has a market cap or net worth of $22.59 million as of July 17, 2026. Its market cap has decreased by -55.93% in one year.
Market Cap
22.59M
Enterprise Value
91.12M
1-Year Change
-55.93%
Ranking
Category
Stock Price
$0.78
ChartMarket Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $22.59M, a decrease of -93.59%. That is a compound annual growth rate of -32.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 22.59M | -28.55% |
| Dec 31, 2025 | 31.61M | -32.41% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Plus Therapeutics | 26.26M |
| IGC Pharma | 25.99M |
| VYNE Therapeutics | 25.16M |
| NeuroSense Therapeutics | 25.10M |
| GridAI Technologies | 25.08M |
| Polyrizon | 23.85M |
| Skye Bioscience | 22.44M |
| Marker Therapeutics | 22.18M |